CBB members Roderick Slavcev, Emmanuel Ho and Marc Aucoin team up to develop DNA-based COVID-19 vaccine
Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.
The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.